SL-101

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSL-101
Drug Alias NameSL-101SL-601
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionInterleukin-3 receptor subunit alpha inhibitors
TargetsInterleukin-3 receptor subunit alpha
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStemline
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStemline
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A